Literature DB >> 19367635

Toxicities induced in cultured human hepatocarcinoma cells exposed to ochratoxin A: oxidative stress and apoptosis status.

Emna El Golli Bennour1, Aïda Rodriguez-Enfedaque, Chayma Bouaziz, Moncef Ladjimi, Flore Renaud, Hassen Bacha.   

Abstract

Ochratoxin A (OTA) is a mycotoxin currently detected in stored animal and human food supplies as well as in human sera worldwide. OTA has diverse toxicological effects; however, the most prominent one is the nephrotoxicity. The present investigation was conducted to determine the molecular aspects of OTA toxicity in cultured human hepatocellular carcinoma cells. With this aim, we have monitored the effects of OTA on (i) cell viability, (ii) heat shock protein expressions as a parameter of protective and adaptive response, (iii) oxidative damage, and (iv) cell death signaling pathway. Our results clearly showed that OTA treatment inhibits cell proliferation, downregulates Hsp 70 and Hsp 27 protein and mRNA levels, and did not induce a significant reactive oxygen species generation. We have also demonstrated a decrease in mitochondrial membrane potential, a cytochrome c release, and an activation of caspase 9 and caspase 3 in response to OTA exposure. Moreover, OTA activates p53 expression, while some of its transcriptional target genes (Bax, Bak, PUMA, and p21) were found to downregulate. According to these data, we concluded that OTA may exert an inhibitory action on the transcriptional process. Besides, oxidative damage is not a major contributor to OTA toxicity. This mycotoxin induces a mitochondrial and caspase-dependent apoptotic cell death, which seems to be mediated by p53 transcriptional independent activities. (c) 2009 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19367635     DOI: 10.1002/jbt.20268

Source DB:  PubMed          Journal:  J Biochem Mol Toxicol        ISSN: 1095-6670            Impact factor:   3.642


  8 in total

1.  miR-122 plays an important role in ochratoxin A-induced hepatocyte apoptosis in vitro and in vivo.

Authors:  Liye Zhu; Tao Yu; Xiaozhe Qi; Bo Yang; Lei Shi; Haoshu Luo; Xiaoyun He; Kunlun Huang; Wentao Xu
Journal:  Toxicol Res (Camb)       Date:  2015-10-08       Impact factor: 3.524

2.  Plasma ochratoxin A levels, food consumption, and risk biomarkers of a representative sample of men and women from the Molise region in Italy.

Authors:  Romina di Giuseppe; Terenzio Bertuzzi; Filippo Rossi; Silvia Rastelli; Annalisa Mulazzi; Jessica Capraro; Amalia de Curtis; Licia Iacoviello; Amedeo Pietri
Journal:  Eur J Nutr       Date:  2011-10-29       Impact factor: 5.614

Review 3.  Mycotoxins are conventional and novel risk biomarkers for hepatocellular carcinoma.

Authors:  Yasunobu Matsuda; Toshifumi Wakai; Masayuki Kubota; Mami Osawa; Ayumi Sanpei; Shun Fujimaki
Journal:  World J Gastroenterol       Date:  2013-05-07       Impact factor: 5.742

4.  Ochratoxin a inhibits mouse embryonic development by activating a mitochondrion-dependent apoptotic signaling pathway.

Authors:  Yan-Der Hsuuw; Wen-Hsiung Chan; Jau-Song Yu
Journal:  Int J Mol Sci       Date:  2013-01-07       Impact factor: 5.923

5.  Selenium Yeast Alleviates Ochratoxin A-Induced Hepatotoxicity via Modulation of the PI3K/AKT and Nrf2/Keap1 Signaling Pathways in Chickens.

Authors:  Peng Li; Kang Li; Chao Zou; Cui Tong; Lin Sun; Zhongjun Cao; Shuhua Yang; Qiufeng Lyu
Journal:  Toxins (Basel)       Date:  2020-02-25       Impact factor: 4.546

6.  Ochratoxin A Induces Oxidative Stress in HepG2 Cells by Impairing the Gene Expression of Antioxidant Enzymes.

Authors:  Enrique García-Pérez; Dojin Ryu; Chan Lee; Hyun Jung Lee
Journal:  Toxins (Basel)       Date:  2021-04-09       Impact factor: 4.546

7.  Protective effects of compound ammonium glycyrrhizin, L‑arginine, silymarin and glucurolactone against liver damage induced by ochratoxin A in primary chicken hepatocytes.

Authors:  Zugong Yu; Feng Wu; Jing Tian; Xuewen Guo; Ran An
Journal:  Mol Med Rep       Date:  2018-07-16       Impact factor: 2.952

8.  Multiple-endpoint in vitro carcinogenicity test in human cell line TK6 distinguishes carcinogens from non-carcinogens and highlights mechanisms of action.

Authors:  Katherine E Chapman; Eleanor C Wilde; Fiona M Chapman; Jatin R Verma; Ume-Kulsoom Shah; Leanne M Stannard; Anna L Seager; James A Tonkin; M Rowan Brown; Ann T Doherty; George E Johnson; Shareen H Doak; Gareth J S Jenkins
Journal:  Arch Toxicol       Date:  2020-09-10       Impact factor: 6.168

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.